Crizotinib in patients with ROS1 NSCLC. Preliminary results of the AcSé trial
Denis Moro-Sibilot,Laura Faivre,Gerard Zalcman,Maurice Perol,Julien Mazieres,Fabrice Barlesi, Josiane Otto,Isabelle Monnet,Alexis Cortot,Marie Wislez,Herve Lena,Pierre Jean Souquet,Sylvie Lantuejoul,Isabelle Rouquette, Anne Mcleer-Florin,Gilbert Ferretti,Natalie Hoog-Labouret, Freferique Nowak,Marta Jimenez,Gilles Vassal JOURNAL OF THORACIC ONCOLOGY（2015）
关键词
NSCLC,Crizotinib,ROS1 translocation,biomarkers
AI 理解论文
溯源树
样例
